SG190131A1 - Cosmetic composition containing an oleanolic acid - Google Patents

Cosmetic composition containing an oleanolic acid Download PDF

Info

Publication number
SG190131A1
SG190131A1 SG2013034087A SG2013034087A SG190131A1 SG 190131 A1 SG190131 A1 SG 190131A1 SG 2013034087 A SG2013034087 A SG 2013034087A SG 2013034087 A SG2013034087 A SG 2013034087A SG 190131 A1 SG190131 A1 SG 190131A1
Authority
SG
Singapore
Prior art keywords
oleanolic acid
cosmetic composition
liposomes
nano
composition
Prior art date
Application number
SG2013034087A
Inventor
Bong Soo Pi
Sung Il Park
Jeong Cheol Ha
Youn Joon Kim
Sang Hun Han
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of SG190131A1 publication Critical patent/SG190131A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a solubilized cosmetic composition which uses an5 oleanolic acid entrapped in nano-liposomes as an active ingredient. The present invention can increase percutaneous absorption of an active ingredient using nano-liposomes to promote synthesis of collagen, thus providing a good anti-wrinkle effect. Also, since other additional raw materials are not used for capsulation, the manufacturing cost of a product can be reduced and a good sensation during use can be provided.10[No Figure]

Description

DESCRIPTION
COSMETIC COMPOSITION CONTAINING AN OLEANOLIC ACID
Technical Field
The present invention relates to a solubilized cosmetic composition containing, as an active ingredient for reducing wrinkles, oleanolic acid encapsulated in nano-liposomes.
Background Art
The skin is the primary barrier of the human body. It protects the organs from changes in temperature and humidity and from damage from the external environment, such as UV radiation or pollutants. It also plays an important role in homeostasis, for example, in regulating body temperature. However, excessive chemical and physical stimulation, stress, malnutrition and the like are harmful to the normal functions of the skin and accelerate skin aging phenomena, such as elasticity loss, keratinization and wrinkle formation. Cosmetic products, which have been used to prevent such phenomena and keep the skin healthy and elastic, have various problems in that they mostly have various problems insufficient effects or cause skin side effects (Korean Patent Laid-
Open Publication No. 10-2010-0064451).
Studies on raw materials having the effect of preventing skin aging without causing skin side effects have been actively conducted, and as a result, it was found that a skin cosmetic composition containing oleanolic acid exhibits an excellent effect of preventing skin aging.
Oleanolic acid, a kind of hydroxy pentacyclic terpene, is the active ingredient of many natural plants, such as Eriobotrya japonica (loquata), Perilla frutescens, Staphyleaholocarpa and the like, and is also found in fruits such as apples or pears. It has pharmacological effects, such as anti- inflammatory, anticancer, anti-allergic, anti-depressant, antibacterial and antifungal effects, and particularly exhibits anti-inflammatory and skin irritation alleviating effects by stimulating the physiological activity of the skin. In addition, with respect to anti-aging functions, oleanolic acid stimulates the synthesis of procollagen important in collagen production, stimulates the synthesis of ceramide and filaggrin, which are important in aging prevention. Moreover, it has a dual anti- aging system which stimulates the production of collagen and prevents the destruction of collagen by inhibiting the activity of MMP-1 that is an enzyme destroying polymer proteins such as produced collagen. Oleanolic acid having excellent effects on the reduction in skin wrinkles as described above has been used as a raw material in various emulsion-type cosmetic formulations to reduce skin wrinkles, but is substantially insoluble in water, and the content of oleanolic acid in cosmetic products is limited due to problems associated with stability and unstable activity.
Particularly, because of this insoluble property, it is impossible to use oleanolic acid directly as a wrinkle reducing agent in solubilized formulations such as cosmetic lotion.
In recent years, it was reported that the stability of oleanolic acid can be increased by encapsulating oleanolic acid into nanoemulsions having a size of 100-150 nm using a skin lipid- like composition and nanotechnology and further encapsulating the oleanolic acid with a polymer emulsifier using the natural polysaccharide inulin and that the encapsulated oleanolic acid can be used in all types of cosmetic formulations. However, oleanolic acid encapsulated as described above should be introduced into emulsion-type formulations at a temperature of 50 °C or below and a low homomixing speed in order to prevent the capsules from being broken during the preparation process. Particularly, problems associated with the stability and unstable activity of oleanolic acid are still present in solubilized formulations. In addition, the use of encapsulated oleanolic acid is more expensive than the use of non-encapsulated oleanolic acid. Further, it can adversely affect the sensory feel of the product, because additional components other than oleanolic acid are used to encapsulate oleanolic acid.
Furthermore, the worldwide market size of certified organic cosmetic products is increasing, and only oleanolic acid is being recognized as a natural functional component for reducing wrinkles. However, when oleanolic acid is encapsulated using a skin lipid-like composition and nanotechnology as described above, it cannot be used as a certified organic cosmetic raw material, because it contains a large number of components which are not acceptable in certified organic cosmetic products.
Disclosure Technical Problem
The present invention has been made in order to solve the above-described problems occurring in the prior art, and an object of the present invention is to provide a solubilized cosmetic composition wherein oleanolic acid having an excellent effect of reducing wrinkles is stably encapsulated in nano-liposomes without using additional components other than oleanolic acid.
Technical Solution
In order to accomplish the above object, the present invention provides a cosmetic composition containing, as an active ingredient, oleanolic acid encapsulated in nano-liposomes.
Advantageous Effects
In the cosmetic composition according to the present invention, oleanolic acid effective in reducing skin wrinkles is stably encapsulated in nano-liposomes, and thus the transdermal absorption rate of oleanolic acid is increased by the nano-liposomes. Thus, the cosmetic composition of the present invention exhibits an excellent effect of reducing skin wrinkles by reducing stimulating collagen synthesis. Moreover, the production cost of the cosmetic composition can be reduced, because an additional raw material for stabilizing oleanolic acid is not used. In addition, the cosmetic composition of the present invention can provide a fresh and moist touch feel after absorption and can satisfy the consumer’s demand for certified organic anti-wrinkle functional cosmetic products, which is increasing worldwide.
Best Mode
The present invention provides a cosmetic composition containing oleanolic acid as an active ingredient, and the cosmetic composition may be formulated in a solubilized form. In the cosmetic composition, oleanolic acid is encapsulated in nano-liposomes and is stabilized by the nano-liposomes. Thus, the stability and solubility of oleanolic acid in the solubilized formulation can be increased, and the transdermal absorption rate thereof can be increased.
Oleanolic acid that is used in the present invention is an unique component recognized as a natural anti-wrinkle functional component. The cosmetic composition of the present invention contains oleanolic acid in an amount of 0.0001-5.0 wt%, and preferably 0.0005-1.0 wt%, based on the total weight of the composition. If the content of oleanolic acid in the composition is less than 0.0001 wt%, a distinct effect cannot be obtained, and if the content of oleanolic acid is more than 5.0 wt%, an increase in the content will not lead to a distinct increase in the anti-wrinkle effect and will adversely affect the stability of the formulation.
Nano-liposomes which are formed during the preparation of the solubilized cosmetic composition of the present invention refer to liposomes having an average particle diameter of 10- 500 nm. The nano-liposomes that are formed in the present invention preferably have a size of 50- 300 nm. If the average particle diameter of the nano-liposomes is more than 300 nm, improvements in skin penetration and formulation stability, among the technical effects to be achieved by the present invention, will be very insignificant.
The nano-liposomes that are formed to stabilize oleanolic acid in the present invention are prepared by a mixture containing a polyol, an oily component, a surfactant, a phospholipid, and water. Also, the nano-liposomes encapsulating oleanolic acid in the solubilized cosmetic composition are naturally formed during the preparation of the solubilized cosmetic composition without having to carry out high-pressure emulsification or a separate preparation process.
The polyol that is used in the inventive solubilized cosmetic composition containing the nano-liposomes is not specifically limited, but is preferably one or more selected from the group consisting of propylene glycol, dipropylene glycol, 1,3-butylene glycol, glycerin, methylpropanediol, isopropylene glycol, pentylene glycol, erythritol, xylitol, sorbitol, and mixtures thereof. In addition, the polyol is used in an amount of 5-50 wt%, and preferably 15-30 wt%, based on the total weight of the solubilized cosmetic composition containing the nano-liposomes.
The oily component that is used in the inventive solubilized cosmetic composition containing the nano-liposomes may be selected from among various components known in the art.
Preferred examples of the oily component include hydrocarbon-based oils such as hexadecane and paraffin oil, ester-based synthetic oils, silicone oils such as dimethicone and cyclodimethicone, animal and plant oils such as sunflower oil, corn oil, soybean oil, avocado oil, sesame oil and fish oil, cthoxviated alkyl ether oil, propoxylated alkyl ether oil, sphingoid lipids such as phytosphingosine, sphingosine and sphinganine, cerebroside cholesterol, sitosterol cholesteryl sulfate, sitosterol sulfate, Coup fatty alcohols, and mixtures thereof. The content of the oily component in the solubilized cosmetic composition is 0.01-10.0 wt%, and preferably 1.0-5.0 wt%, based on the total weight of the solubilized cosmetic composition comprising the nano-liposomes.
The surfactant that is used in the solubilized cosmetic composition of the present invention may be any surfactant known in the art. Examples of the surfactant that is used in the present invention include anionic surfactants, cationic surfactants, amphoteric surfactants and nonionic surfactants. Preferably, anionic surfactants and nonionic surfactants may be used in the present invention. Specific examples of the anionic surfactants include atkyi acyl glutamate, alkyl phosphate, alkyl lactate, dialkyl phosphate and trialkyl phosphate. Specific examples of the non- ionic surfactants include polysorbate, alkoxylated alkyl ether, alkoxylated alkyl ester, alkyl polyglycoside, polvalyeeryl ester and sugar ester. The content of the surfactant in the solubilized cosmetic cornposition 1s 0.001-5.0 wt%, and preferably 0.1-1.0 wt%, based on the total weight of the solubilized cosmetic composition comprising the nano-liposomes.
A phospholipid in the nano-liposomes that are formed in the present invention is an amphoteric lipid, and examples thereof includes natural phospholipids (e.g., egg lecithin, soybean lecithin or sphingomyelin) and synthetic phospholipids (e.g., dipalmitoylphosphatidylcholine or hydrogenated lecithin), preferably lecithin. More preferably, the phospholipid is a naturally occurring saturated or unsaturated lecithin extracted from soybean or egg yolk. In general, the naturally occurring lecithin has a phosphatidylcholine content of 23-95% and a phosphatidylethanolamine content of 20% or less. The content of the phospholipid in the preparation of the inventive solubilized cosmetic composition containing the nano-liposomes is 0.01-5.0 wt%, and preferably 0.5-2.0 wt%, based on the total weight of the solubilized cosmetic composition.
Water in the inventive solubilized cosmetic composition containing the nano-liposomes is generally distilled water and is used in an amount of 25.0-90.0 wt% based on the total weight of the solubilized cosmetic composition.
The solubilized cosmetic composition of the present invention contains oleanolic acid, and thus can particularly be used as an anti-aging composition having an excellent effect of reducing skin wrinkles.
The formulation of the composition of the present invention is not specifically limited. In view of a transparent or suspended appearance and advantages in use, the composition of the present invention may be used as basic cosmetic compositions such as skin softener, nourishing lotion, spray, mist or gel, hair cosmetic compositions such as hair growth agents, including hair tonic, hair essence or hair treatment, and other medical drugs and quasi-drgs. In addition, it may also be used as a skin wrinkle-reducing agent, which shows an excellent effect and is safe without side effects when being applied to the hurnan skin.
The cosmetic composition according to the present invention may contain additives which are generally used in the cosmetic field or the skin science field, for example, fatty substance, organic solvent, solubilizing agent, thickener, gelling agent, softener, antioxidant, suspending agent, stabilizer, foaming agent, fragrance, surfactant, water, ionic or non-ionic emulsifying agent, filler, metal ion sequestering agent, metal ion chelating agent, preservative, vitamins, blocker,
wetting agent, essential oil, dye, pigment, hydrophilic or hydrophobic activator, lipid vesicle, or other components which are generally used in cosmetic products. These additives are introduced in amounts which are generally used in the cosmetic field or the skin science field.
Mode for Invention
Hereinafter, the present invention will be described in further detail with reference to examples and test examples. It is to be understood, however, that the following examples, test examples and preparation examples are for illustrative purposes only and are not intended to limit the scope of the present invention.
Reference Example 1: Preparation of solubilized cosmetic lotion containing oleanolic acid stabilized with nano-liposomes
According to the compositions shown in Table 1 below, wrinkle-reducing solubilized cosmetic lotions of Examples 1 to 3 and Comparative Example 1 to 4 were prepared.
Lotions of Examples 1 to 3 are solubilized cosmetic lotions containing nano-liposomes formed according to the present invention, and lotions of Comparative Examples 1 and 2 contain general solubilizing agents different from those of Examples 1 to 3, and lotion of Comparative
Example 3 contains an encapsulated oleanolic acid nanobase. Lotion of Comparative Example 4 is a lotion containing an oleanolic acid dissolved in a 4:1 mixture of ethanol and propylene glycol.
Table 1 (unit: wt%)
Component Exampl | Exampl | Exampl | Compa [Compa |Compa |Compa el e e3 rative |rative [rative |rative 2 Exampl | Exampl | Exampl | Exampl el e?2 e3 ed
Hydrogenated lecithin 005 [02 io | - Joa [
PEG-60 hydrogenated castoroil |- |- | [18 [J]. |- 3 |caprylic/capryl glucoside - Be 4 [Propylene glycol 5 |Glyeerin ~~ |400 400 [400 [400 [400 [400 |- 6 |Dicaprylyl carbonate as. [gs gs. gs. gs gs. [ [7_|Oleanolic acid 005 005 [00s [005 [005 |- [0.05
8 [Preservative gs. gs. gs. [gs [gs gs.
O |Fragmnce ~~ gs. gs. gs. [gs gs. Jgs 11 [Purifiedwater [balance |balance [balance [balance [balance [balance |-
Dermofeel PA-3 002 [002 002 [002 1002 002 [ 13 [Betaine ~~ [200 200 [200 [200 [200 [2.00 |- 14 Xanthangum ~~ Jo2 02 Joa [02 Joa [02 15 |Encapsulated oleanolic nanobase 25 (containing 0.05 wt% oleanolic acid)
The lotions were prepared in the following manner. 1) Components 1 to 3 and polyol components 4 to 5 were mixed and dissolved by heating to 80 °C, and then components 6 to 9 were added thereto and uniformly mixed. 2) The mixture of step 1) was cooled to 65 °C, and then ethanol (component 10) was added thereto and sufficiently mixed. 3) Aqueous part components 11 to 14 were mixed uniformly and heated to 65 °C, after which the mixture was uniformly mixed with the mixture of step 2). 4) The mixture of step 3) was cooled to room temperature and stored.
Meanwhile, in the preparation of the lotion of Comparative Example 3, an encapsulated oleanolic acid nanobase (component 15) was added after step 3).
Test Example 1: Evaluation of stability of composition
In order to evaluate the stability of the wrinkle-reducing cosmetic composition with time, the solubilized cosmetic lotions prepared in Examples 1 to 3 and Comparative Examples 1 to 4 were stored for 1 month in each of a room temperature incubator, a 45 °C incubator and an incubator that was circulated from -10 °C to 45 °C at 12-hr intervals, and then the changes in the appearances of the lotions were observed.
Table 2
Items |Kind of surfactant Average | Stability (solubilizing agent) par ticl e siz e (n m)
Room temperature e|45 °C Circulated temperature
Next (1 4 Next (1 4 Next (1 4 da |week [week | day |week [week | day |week [week y S S S
Examp|0.05% hydrogenated [376 good [good |Separ |good [Separ |Separ |good |good |Separ lel lecithin ated ated [ated ated
Examp|0.20% hydrogenated [257 good [good |good |good [good [good |good |good [good le2 [lecithin
Examp|1.00% hydrogenated [234 good [good |Preci |good [good |Preci |good |good |Preci le3 |lecithin pitate pitate pitate d d d
Comp [1.80% PEG-60 245 Separ Separ Separ arative | hydrogenated castor oil ated ated ated
Examp le 1
Comp |3.60% caprylic/capryl (241 Separ Separ Separ arative | glucoside ated ated ated
Examp le 2
Comp |0.20% hydrogenated (240 good [good |good |good [good |Separ|good |Separ arative | lecithin ated ated
Examp le 3
As can be seen from the results in Table 2 above, the lotions of Examples 1 to 3, which contain oleanolic acid encapsulated in nano-liposomes, were stable over a long period of time compared to the lotions of Comparative Examples 1 and 2, which contain other general solubilizing agents. Also, from the comparison between Example 2 and Comparative Examples 1 and 2, it can be seen that the amount of the surfactant used in Example 2 in which oleanolic acid was stabilized by encapsulation in nano-liposomes was significantly smaller than the amount of the surfactant used in Comparative Examples 1 and 2. This suggests that, when oleanolic acid is encapsulated in nano-liposomes formed, the amount of the surfactant to be used in the formulation can be significantly reduced, and the risk of skin irritation, which is caused by the use of a large amount of a surfactant, can be avoided.
Test Example 2: Comparison of sensory feeling between a composition containing oleanolic acid stabilized with nano-liposomes and a composition containing encapsulated oleanolic acid
In order to evaluate the sensory feelings of the compositions of Example 2 and
Comparative Example 3, a sensory test was performed for the wrinkle-reducing cosmetic compositions prepared in Example 2 and Comparative Example 3. Twenty 25-35 years old women were selected as subjects. Each of the cosmetic compositions was applied to the back of the hand of each subject according to a general method, and then the satisfaction of the sensory feeling of each composition was evaluated. The sensory evaluation of each composition was performed with respect to a total of 4 items, including stickiness, absorption feeling, moist feeling and nourishing feeling, on the basis of the following criteria: very superior (10), superior (7.5), moderate (5), inferior (2.5) and very inferior (0). The values of the evaluation were averaged and shown in Table 3 below.
Table 3 feeling 3
Absorption feeling [98 [52
Nourishing feeling [69 [63
From the comparison between the composition of Example 2, which contains oleanolic acid stabilized with nano-liposomes formed in the formulation, and the composition of
Comparative Example 3, which contains encapsulated oleanolic acid, it can be seen that, because the amount of the stabilizing agent used to prepared the encapsulated oleanolic acid nanobase in
Comparative Example 3 was larger by about 2.4 wt% than that in Example 2, the stabilizing agent in Comparative Example 3 had an adverse effect on the sensory feeling. Also, as can be seen in
Table 3 above, the sensory feeling of the formulation (Example 2) containing oleanolic acid stabilized with nano-liposomes formed therein is significantly excellent compared to the formulation of Comparative Example 3.
Test Example 3: Measurement of effect on stimulation of collagen biosynthesis
The effect of the composition of Example 2 on the stimulation of collagen biosynthesis was measured comparatively with those of tocopherol and EGCG, which are known to stimulate collagen biosynthesis. First, human fibroblasts (PromoCell, Germany) were seeded in a 24-well plate at a density of 10° cells and cultured to a confluence of about 90%. The cells were cultured in serum-free DMEM medium for 24 hours, and then treated with 10™ M of each of the composition of Example 2, tocopherol and EGCG in serum-free medium. Then, the cells were incubated in a
CO; incubator for 24 hours. The supernatant of each of the cell cultures was collected, and the amount of procollagen in the supernatant was measured using a procollagen type (I) ELISA kit.
The results of the measurement are shown in Table 4 below. In Table 4, the values of synthesis are expressed as percentages relative to the untreated group taken as 100.
Table 4 =
As can be seen in Table 4 above, the composition of Example 2 stimulates collagen biosynthesis and has a significantly better effect on the stimulation of collagen biosynthesis compared to tocopherol and EGCG, which are known to stimulate collagen biosynthesis.
Test Example 4: Measurement of absorption into skin
Absorption into the skin was measured on the skin of guinea pigs using Frantz permeation cells. Immediately before the experiment, abdominal skin of guinea pigs was collected and cut to a size of 1 cm, The cut skin was placed in a permeation cell having a permeation lens diameter of 0.9 cm and was fixed by a clamp. 0.2 g of each of the sample of Comparative Example 4, which contains a solution of oleanolic acid in ethanol and propylene glycol (4:1), and the sample of
Example 2, which contains oleanolic acid stabilized with nano-liposomes, was applied to one side of the skin (donor container), and the other side (receptor container) was brought into contact with a solvent consisting of a 4:1 mixture of purified water and ethanol. The temperature during the experiment was maintained at 32 °C (actual skin temperature). After the start of the experiment, a portion of the solvent was collected at intervals of a given time, and then the amount of oleanolic acid absorbed into the skin was measured by HPLC. The results of the measurement were expressed as skin absorption per applied concentration (48/CT/wt%) and are shown in Table 5 below.
HPLC analysis conditions - column: Waters Novapak C18 (3.9 mm * 250 mm, 4 um) - solvent flow rate: 1 M¢/min - detection UV: 210 nm - sample measurement concentration: 10-100 ug/mL - injected sample amount: 20 ull - eluent: MeOH/0.1% H3:PO4 = 82/18
Table 5 o oo jo 000000] s 000 [3613 00 85 00
As can be seen from the results in Table 5 above, the composition of Example 2, which contains oleanolic acid stabilized with nano-liposomes formed therein, showed a significantly large amount of transdermal absorption compared to that of Comparative Example 2.

Claims (7)

  1. I. A cosmetic composition containing, as an active ingredient, oleanolic acid encapsulated in nano-liposomes.
  2. 2. The cosmetic composition of claim 1, wherein the oleanolic acid is contained in an amount of 0.0001-5.0 wt% based on the total weight of the composition.
  3. 3. The cosmetic composition of claim 1, wherein the nano-liposomes having the oleanolic acid encapsulated therein is contained in an amount of 0.001-50 wt% based on the total weight of the composition.
  4. 4. The cosmetic composition of claim 1, wherein the nano-liposomes have an average particle diameter of 50-300 nm.
  5. 5. The cosmetic composition of claims 1 to 4, wherein the composition is a solubilized formulation.
  6. 6. The cosmetic composition of claim 1, wherein the composition is for anti-aging.
  7. 7. The cosmetic composition of claim 1, wherein the composition is for stimulating collagen biosynthesis.
SG2013034087A 2010-11-22 2011-11-17 Cosmetic composition containing an oleanolic acid SG190131A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100116288A KR101821207B1 (en) 2010-11-22 2010-11-22 Solubilization cosmetic composition containing oleanolic acid
PCT/KR2011/008785 WO2012070804A2 (en) 2010-11-22 2011-11-17 Cosmetic composition containing an oleanolic acid

Publications (1)

Publication Number Publication Date
SG190131A1 true SG190131A1 (en) 2013-06-28

Family

ID=46146254

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2013034087A SG190131A1 (en) 2010-11-22 2011-11-17 Cosmetic composition containing an oleanolic acid

Country Status (6)

Country Link
JP (2) JP6321962B2 (en)
KR (1) KR101821207B1 (en)
CN (1) CN103221028B (en)
HK (1) HK1186963A1 (en)
SG (1) SG190131A1 (en)
WO (1) WO2012070804A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103830116B (en) * 2014-03-26 2017-01-04 清华大学 Ligustilide prevents purposes and the using method of skin photoage skin care item in preparation
CN103830118A (en) * 2014-03-26 2014-06-04 清华大学 Application and use method of salidroside in preparing skin-care product for preventing skin photoaging
JP6605794B2 (en) * 2014-09-22 2019-11-13 株式会社ファンケル Arginase 1 production promoter
KR102621819B1 (en) * 2015-03-02 2024-01-08 (주)아모레퍼시픽 Nano multilamella liposome containg skin lipid ingredient and manufacturing method thereof
CN106309313A (en) * 2016-08-24 2017-01-11 彭友莲 Whitening facial cleanser and preparing method thereof
KR20190079276A (en) * 2017-12-27 2019-07-05 정한수 Anti-aging cosmetics with nanoparticles-ingredient that solubilized insoluble oligoanionic acid and manufacturing method for anti-aging cosmetics
CN108403751B (en) * 2018-05-23 2021-04-06 阜阳师范学院 Application of triterpenoid saponin in trichosanthes peel
KR20210120633A (en) 2020-03-27 2021-10-07 (주)아모레퍼시픽 Sheet type mask gel composition, mask sheet comprising the same and manufacturing method of mask sheet
CN113413325B (en) * 2021-05-31 2022-04-05 宝萃生物科技有限公司 Lip plumping composition and preparation method and application thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100489701B1 (en) * 2002-10-09 2005-05-16 주식회사 태평양 Submicron-liposome containing highly concentrated triterpenoid and method for preparing thereof
KR100654846B1 (en) * 2004-12-02 2006-12-06 한국콜마 주식회사 Cosmetic composition comprising nano size liposome and oil in water type emulsion and manufacturing method thereof
KR20060087817A (en) * 2005-01-31 2006-08-03 주식회사 태평양 Anti-aging cosmetic composition
KR100654841B1 (en) * 2005-06-27 2006-12-06 한국콜마 주식회사 Lipid solution composition and method for preparing nano particle cosmetics having analogous structure and composition of human skin and promoting the transepidermal absorption of physiologically active substances using the same
WO2007078060A1 (en) * 2005-12-30 2007-07-12 Amorepacific Corporation Polymer-liposome nano-complexes and the preparation method thereof, and the composition of skin external application containing the same
JP2007224012A (en) * 2006-01-30 2007-09-06 Fujifilm Corp Enzymatically crosslinked protein nanoparticle
ES2286953B1 (en) * 2006-05-18 2008-12-16 Universidad De Granada FORMULATION OF NATURAL TRITERPENES AND BIOPHENOLS OBTAINED FROM THE OLEA GENDER IN LIPOSOMAS.
CN1923178A (en) * 2006-08-22 2007-03-07 河南大学 Oleanolic acid liposome preparation, freeze dried powder injecta thereof and its preparation
KR20080038812A (en) * 2006-10-31 2008-05-07 (주)아모레퍼시픽 A cosmetic of sheet-type containing unsoluble material stably in a low viscosity level state
KR100792629B1 (en) * 2006-11-20 2008-01-09 (주)아모레퍼시픽 Skin whitening cosmetic composition containing oldenlandia diffusa extract stabilized with nano-liposome
JP2008297241A (en) * 2007-05-31 2008-12-11 Fujifilm Corp Anti-acne skin agent for external use
CN101843623B (en) * 2010-04-09 2012-03-14 澳门理工学院 External fat-increasing preparation and application thereof
CN101923178B (en) 2010-08-16 2012-05-23 中国海洋石油总公司 Sub-pixel matching-based towline dynamic acquisition influence eliminating method

Also Published As

Publication number Publication date
KR20120054906A (en) 2012-05-31
WO2012070804A2 (en) 2012-05-31
JP6321962B2 (en) 2018-05-09
WO2012070804A3 (en) 2012-07-19
JP2013542984A (en) 2013-11-28
KR101821207B1 (en) 2018-01-24
CN103221028B (en) 2016-04-20
HK1186963A1 (en) 2014-03-28
JP6231624B2 (en) 2017-11-15
CN103221028A (en) 2013-07-24
JP2016222694A (en) 2016-12-28

Similar Documents

Publication Publication Date Title
SG190131A1 (en) Cosmetic composition containing an oleanolic acid
KR20070081192A (en) Cosmetic compostion comprising liposome incorporating oryzanol, rice bran oil and phospholipid
KR20130023912A (en) Peptides stabilized using liposome and cosmeceutical composition thereof
KR20180027375A (en) Compositions for Moisturizing Skin Containing Vegetable Vernix Ingredients
KR101595530B1 (en) Liposome composition having excellent effect of skin wrinkle improvement and skin whitening for accelerating percutaneous absorption
KR102078667B1 (en) Cosmetic composition containg nanoemulsion encapsulated with 7-dehydrocholesterol, cholesterol and stearic acid in inner phase of hyaluronate-ceramide NP complex and manufacturing method thereof
KR20040101588A (en) Cosmetic Compostion for Preventing Skin Aging Comprising Plant Extract as Oriental Medicine Stabilized in Nanoliposome
KR20150077214A (en) Liquid crystal cosmetic composition having similar skin lipid composition and containing glucosylceramide, and preparation method thereof
KR101862039B1 (en) A cosmetic composition containing spicule powder and natural complex extract stabilized in nanoliposome
KR101325553B1 (en) Cosmetic Composition for Protecting Skin Comprising Aminolevulinic acid Contained in Liquid Crystal Base
WO2015147137A1 (en) Ceramide-formulated external agent composition
KR101549624B1 (en) Temperature Sensitive Cosmetic Composition
KR20110078955A (en) Cosmetic composition comprising moisture quality component as active ingredient
KR100858628B1 (en) Cosmetic Composition for alleviating Skin Irritation Comprising Rumex Crispus L. Extract Stabilized in Nanoliposome
KR100681703B1 (en) Cosmetic composition for enhancement of skin luster comprising the mixed extract of panax ginseng, sohizophyllum commune and phellodendron amurense ruprecht stabilized in nanoliposome
KR100888752B1 (en) External dermal agent
KR20120037639A (en) Capsulation method and cosmetic containing this capsulation for maximizing efficacy of sodium polygamma glutamate
KR100858626B1 (en) Cosmetic Composition for Protecting lip Comprising Ceramide and Synthetic Palmitoylpentapeptide as an Active Ingredient
JP4592347B2 (en) External preparation composition
KR20150078137A (en) Cosmetic composition for improving skin wrinkle
JP2004051561A (en) Skin cosmetic composition
EP2745835B1 (en) Novel vesicle for topical application in pharmacy and cosmetics
JP5329489B2 (en) External preparation composition
CN110652460B (en) Compositions containing linoleic acid
KR20130057634A (en) Method of stabilizing egcg and composition for whitening skin containing egcg